Multi-dimensional scores to predict mortality in patients with idiopathic pulmonary fibrosis undergoing lung transplantation assessment

Respir Med. 2017 Apr:125:65-71. doi: 10.1016/j.rmed.2017.03.006. Epub 2017 Mar 6.

Abstract

Background: The heterogeneous progression of idiopathic pulmonary fibrosis (IPF) makes prognostication difficult and contributes to high mortality on the waitlist for lung transplantation (LTx). Multi-dimensional scores (Composite Physiologic index [CPI], [Gender-Age-Physiology [GAP]; RIsk Stratification scorE [RISE]) demonstrated enhanced predictive power towards outcome in IPF. The lung allocation score (LAS) is a multi-dimensional tool commonly used to stratify patients assessed for LTx. We sought to investigate whether IPF-specific multi-dimensional scores predict mortality in patients with IPF assessed for LTx.

Methods: The study included 302 patients with IPF who underwent a LTx assessment (2003-2014). Multi-dimensional scores were calculated. The primary outcome was 12-month mortality after assessment. LTx was considered as competing event in all analyses.

Results: At the end of the observation period, there were 134 transplants, 63 deaths, and 105 patients were alive without LTx. Multi-dimensional scores predicted mortality with accuracy similar to LAS, and superior to that of individual variables: area under the curve (AUC) for LAS was 0.78 (sensitivity 71%, specificity 86%); CPI 0.75 (sensitivity 67%, specificity 82%); GAP 0.67 (sensitivity 59%, specificity 74%); RISE 0.78 (sensitivity 71%, specificity 84%). A separate analysis conducted only in patients actively listed for LTx (n = 247; 50 deaths) yielded similar results.

Conclusions: In patients with IPF assessed for LTx as well as in those actually listed, multi-dimensional scores predict mortality better than individual variables, and with accuracy similar to the LAS. If validated, multi-dimensional scores may serve as inexpensive tools to guide decisions on the timing of referral and listing for LTx.

Keywords: Idiopathic pulmonary fibrosis; Interstitial lung disease; Lung transplantation; Survival.

MeSH terms

  • Aged
  • Disease Progression
  • Female
  • Forced Expiratory Volume / physiology
  • Humans
  • Idiopathic Pulmonary Fibrosis / epidemiology
  • Idiopathic Pulmonary Fibrosis / mortality*
  • Idiopathic Pulmonary Fibrosis / physiopathology
  • Idiopathic Pulmonary Fibrosis / surgery*
  • Incidence
  • Lung Diseases, Interstitial / complications
  • Lung Diseases, Interstitial / mortality
  • Lung Diseases, Interstitial / physiopathology*
  • Lung Transplantation / adverse effects
  • Lung Transplantation / methods*
  • Male
  • Middle Aged
  • Organ Dysfunction Scores
  • Outcome Assessment, Health Care
  • Predictive Value of Tests
  • Respiratory Function Tests / methods
  • Retrospective Studies
  • Survival
  • Vital Capacity / physiology
  • Waiting Lists
  • Walk Test / methods